Neurobiological treatment is a therapy for disorders, such as depression, anxiety, PTSD, OCD, and bipolar disorder, based on the physical and chemical makeup of the brain. Neurobiology is the study of how the brain works, and neurobiological treatments use medications and/or cognitive therapies tailored to an individual's specific needs, in order to correct imbalances or deficiencies in the brain. Neurobiological treatments aim to correct “faulty” neural pathways, or connections between neurons in order to reduce the symptoms of a mental disorder. Neurobiological treatments generally involve a combination of several conditions: an understanding of the patient’s biological trautma history; the individual's family, social, and environmental context; the individual's personilized neurobiological makeup, and; cognitive behavioral therapies. Neurobiological treatments often focus on the transmission of signals within the brain from one neuron to another, in order to improve the mental state of the patient. Medication is often used in neurobiological treatments. For example, antidepressant and antipsychotic medication might be prescribed for individuals with depression or anxiety. Antipsychotics can help balance serotonin, dopamine, and other neurotransmitters in the brain, while antidepressants can also help reduce the symptoms of depression. Other drugs may be prescribed to help reduce the symptoms associated with mental health disorders, such as mania or psychosis. Cognitive behavioral treatments are also often used in neurobiological treatments. These therapies involve learning coping strategies to manage emotions, thoughts, and behaviors, as well as learning more efficient ways to regulate emotions and reduce stress. This may include relaxation techniques, problem-solving skills, and techniques to help understand and manage one’s emotions. Neurobiological therapies are highly individualized, and thus treatment must be tailored to each person’s particular history, needs, and genetic make-up. It is important to find a treatment plan that is both effective and acceptable to the individual, as well as to create supportive relationships with others who are involved in the individual’s treatment. It is also important to remember that, while these treatments can help improve symptoms, there is no “cure” for mental illness, and so it is important to continue treatment even after symptoms have improved.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom